Autopsy report · NCT00595023

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

“GeneSearch™ BLN Assay has been voluntarily withdrawn from the US market.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 233 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Janssen Diagnostics, LLC

Sponsor type

Industry

Conditions

Breast Cancer

Interventions

GeneSearch™ Breast Lymph Node (BLN) Assay

Participants

233

Sites

6

Countries

United States

Trials that died the same way

• Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
  “The clinical trial was withdrawn due to a commercial decision.” (59% match in meaning)
• HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
  “The study was stopped early due to increased global access to genomic screening. It is no longer economical to continue with this particular single-gene screening protocol.” (59% match in meaning)
• Medication Use Among American Indians Adults
  “The study has not been stopped. The study does not qualify as a clinical trial so it was withdrawn from clinicaltrials.gov.” (57% match in meaning)
• MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
  “Product withdrawn from clinical development” (57% match in meaning)
• A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria
  “The study was withdrawn because BioMarin decided to end the overall development program. The study withdrawal was not due to any patient safety concerns.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.